Literature DB >> 9124854

Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes.

R N Charrel1, J M Pagès, P De Micco, M Mallea.   

Abstract

We evaluated the prevalence of impermeability as a mechanism associated with resistance against beta-lactam antibiotics in members of the family Enterobacteriaceae. During a 1-year period, 80 strains were selected from 3,110 routinely isolated strains according to their noticeable cross-resistance pattern to cephalosporins. They were tested for (i) outer membrane nonspecific porins involved in the entry of small hydrophilic molecules; (ii) the MICs of cefepime, cefotaxime, imipenem, and moxalactam; and (iii) beta-lactamase production. Immunological investigations using specific probes showed that 23 of 80 strains presented an alteration of the porin content, most of them expressing an additional resistance mechanism. The prevalence of this porin-deficient phenotype is especially high in Enterobacter aerogenes and concerns 6.4% of the clinical isolates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9124854      PMCID: PMC163635     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations.

Authors:  H Leying; W Cullmann; W Dick
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

2.  Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.

Authors:  H Nikaido; W Liu; E Y Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

3.  Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes.

Authors:  J M Hopkins; K J Towner
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

Review 4.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 5.  Inactivation of antibiotics and the dissemination of resistance genes.

Authors:  J Davies
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

6.  Isolation of Enterobacter aerogenes susceptible to beta-lactam antibiotics despite high level beta-lactamase production.

Authors:  M A Mellencamp; J S Roccaforte; L C Preheim; C C Sanders; C A Anene; M J Bittner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

7.  Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp.

Authors:  E Lindh; K Dornbusch; K Jalakas; A Forsgren
Journal:  APMIS       Date:  1990-05       Impact factor: 3.205

8.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Authors:  E H Lee; M H Nicolas; M D Kitzis; G Pialoux; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital.

Authors:  C de Champs; D Sirot; C Chanal; M C Poupart; M P Dumas; J Sirot
Journal:  J Antimicrob Chemother       Date:  1991-04       Impact factor: 5.790

10.  Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.

Authors:  K Bush; S K Tanaka; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

View more
  38 in total

1.  Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; A Pechinot; J M Duez; M Pruneaux; F Garel; A Kazmierczak; R Labia
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains.

Authors:  Stéphane Gayet; Renaud Chollet; Gérard Molle; Jean-Marie Pagès; Jacqueline Chevalier
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.

Authors:  D M Livermore; M W Carter; S Bagel; B Wiedemann; F Baquero; E Loza; H P Endtz; N van Den Braak; C J Fernandes; L Fernandes; N Frimodt-Moller; L S Rasmussen; H Giamarellou; E Giamarellos-Bourboulis; V Jarlier; J Nguyen; C E Nord; M J Struelens; C Nonhoff; J Turnidge; J Bell; R Zbinden; S Pfister; L Mixson; D L Shungu
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 4.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

5.  Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins.

Authors:  Charléric Bornet; Nathalie Saint; Lilia Fetnaci; Myrielle Dupont; Anne Davin-Régli; Claude Bollet; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

6.  Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel.

Authors:  V Simonet; M Malléa; J M Pagès
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 7.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.

Authors:  Y De Gheldre; M J Struelens; Y Glupczynski; P De Mol; N Maes; C Nonhoff; H Chetoui; C Sion; O Ronveaux; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

9.  Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

Authors:  G S Babini; M Yuan; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

10.  Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses.

Authors:  Lorna E T Stearne; Doret van Boxtel; Nicole Lemmens; Wil H F Goessens; Johan W Mouton; Inge C Gyssens
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.